Get App
Moneycontrol

Co-Partners

Associate Partners

Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Yearly Results - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 16:00
2658.95
-3.6 (-0.14%)
VOLUME 17,736
LIVE
NSE
May 22, 15:57
2657.75
-9.25 (-0.35%)
VOLUME 765,196
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Yearly Results of Dr Reddys Laboratories

------------------- in Rs. Cr. -------------------
Mar '19 Mar '18 Mar '17 Mar '16 Mar '15
Net Sales/Income from operations 10,466.70 9,302.60 9,628.10 10,234.80 9,927.45
Other Operating Income 158.80 56.70 91.70 57.10 83.49
Total Income From Operations 10,625.50 9,359.30 9,719.80 10,291.90 10,010.94
EXPENDITURE
Consumption of Raw Materials 2,103.20 2,011.00 1,817.60 2,072.70 2,322.63
Purchase of Traded Goods 868.60 671.60 671.50 610.40 526.06
Increase/Decrease in Stocks 66.00 -51.60 1.90 -28.80 -28.96
Power & Fuel -- -- -- -- --
Employees Cost 1,931.90 1,843.00 1,803.30 1,693.40 1,490.86
Depreciation 780.60 774.10 735.10 927.50 490.23
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- 998.50 649.50 1,063.50
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 3,356.10 3,555.40 2,681.40 2,951.40 2,245.85
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,519.10 555.80 1,010.50 1,415.80 1,900.77
Other Income 238.40 204.00 591.20 324.90 222.85
P/L Before Int., Excpt. Items & Tax 1,757.50 759.80 1,601.70 1,740.70 2,123.62
Interest 56.80 62.80 57.20 64.10 63.80
P/L Before Exceptional Items & Tax 1,700.70 697.00 1,544.50 1,676.60 2,059.82
Exceptional Items -- -- -- -- --
P/L Before Tax 1,700.70 697.00 1,544.50 1,676.60 2,059.82
Tax 423.40 130.10 160.40 302.30 380.47
P/L After Tax from Ordinary Activities 1,277.30 566.90 1,384.10 1,374.30 1,679.35
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 1,277.30 566.90 1,384.10 1,374.30 1,679.35
Equity Share Capital 83.00 83.00 82.90 85.30 85.20
Reserves Excluding Revaluation Reserves 12,601.10 11,724.80 11,517.70 11,520.10 10,548.80
Equity Dividend Rate (%) 400.00 400.00 400.00 400.00 400.00
EPS Before Extra Ordinary
Basic EPS 76.98 34.19 83.05 80.59 98.60
Diluted EPS 76.85 34.12 82.88 80.34 98.18
EPS After Extra Ordinary
Basic EPS 76.98 34.19 83.05 80.59 98.60
Diluted EPS 76.85 34.12 82.88 80.34 98.18
Public Share Holding
No Of Shares (Crores) -- -- -- -- 9.82
Share Holding (%) -- -- -- -- 57.63
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- 4.34
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- 100.00
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- 25.48
Notes Notes To The Accounts
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for drreddyslaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.